|7.91||-0.26 / -3.18%|
Data as of 4:00pm ET
|7.89||-0.02 / -0.25%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 18.50, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +133.88% increase from the last price of 7.91.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.